IR-Med, Inc. financial data

Symbol
IRME on OTC
Industry
Electromedical & Electrotherapeutic Apparatus
Location
C/O Aboudi Legal Group Pllc, 745 5 Th Ave, Suite 500, New York, NY
State of incorporation
NV
Fiscal year end
December 31
Latest financial report
10-Q - Q3 2024 - Nov 14, 2024

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 312 %
Debt-to-equity 366 % +988%
Return On Equity -1.8K % -491%
Return On Assets -386 % -69.5%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 71M shares +1.55%
Common Stock, Shares, Outstanding 69.9M shares +1.63%
Entity Public Float 40.2M USD -47.2%
Common Stock, Value, Issued 70K USD +1.45%
Weighted Average Number of Shares Outstanding, Basic 70.8M shares +2.79%
Weighted Average Number of Shares Outstanding, Diluted 70.8M shares +2.79%

Income Statement

Label TTM Value / Value Unit Change %
Research and Development Expense 985K USD -53.1%
General and Administrative Expense 1.48M USD -39.1%
Operating Income (Loss) -2.88M USD +49.6%
Nonoperating Income (Expense) -13K USD +23.5%
Net Income (Loss) Attributable to Parent -2.89M USD +49.5%
Earnings Per Share, Basic -0.04 USD/shares +60%
Earnings Per Share, Diluted -0.04 USD/shares +50%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 392K USD -74.3%
Accounts Receivable, after Allowance for Credit Loss, Current 51K USD -38.6%
Assets, Current 443K USD -72.4%
Property, Plant and Equipment, Net 39K USD -29.1%
Operating Lease, Right-of-Use Asset 40K USD -60%
Assets 533K USD -69.9%
Accounts Payable, Current 68K USD
Employee-related Liabilities, Current 66K USD
Accrued Liabilities, Current 157K USD
Liabilities, Current 473K USD -28.6%
Long-term Debt and Lease Obligation 13K USD -83.3%
Operating Lease, Liability, Noncurrent 2K USD
Liabilities 531K USD -5.35%
Retained Earnings (Accumulated Deficit) -16.5M USD -21.3%
Stockholders' Equity Attributable to Parent 363K USD -81.9%
Liabilities and Equity 533K USD -69.9%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities -358K USD +60.2%
Net Cash Provided by (Used in) Investing Activities -20K USD -186%
Common Stock, Shares Authorized 600M shares +140%
Common Stock, Shares, Issued 70.8M shares +1.3%
Common Stock, Par or Stated Value Per Share 0 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect -359K USD +60.1%
Deferred Tax Assets, Valuation Allowance 2.1M USD +44.3%
Deferred Tax Assets, Gross 2.12M USD +42.2%
Operating Lease, Liability 39K USD -65.8%
Depreciation 9K USD +125%
Payments to Acquire Property, Plant, and Equipment 11K USD +57.1%
Lessee, Operating Lease, Liability, to be Paid 50K USD -58.3%
Property, Plant and Equipment, Gross 93K USD +2.2%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount 11K USD +83.3%
Deferred Tax Assets, Operating Loss Carryforwards 1.68M USD +50.1%
Additional Paid in Capital 16.4M USD +11.4%
Share-based Payment Arrangement, Expense 53K USD